PT - JOURNAL ARTICLE AU - Jennifer K. Ferris AU - Brian Greeley AU - Irene M. Vavasour AU - Sarah N. Kraeutner AU - Shie Rinat AU - Joel Ramirez AU - Sandra E. Black AU - Lara A. Boyd TI - In vivo myelin imaging and tissue microstructure in white matter hyperintensities and perilesional white matter AID - 10.1101/2021.11.23.21266731 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.23.21266731 4099 - http://medrxiv.org/content/early/2021/11/24/2021.11.23.21266731.short 4100 - http://medrxiv.org/content/early/2021/11/24/2021.11.23.21266731.full AB - Introduction White Matter hyperintensities (WMHs) relate to cognitive decline in aging, due to their deleterious effect on white matter structure. Diffusion tensor imaging (DTI) detects changes to white matter microstructure, both within the WMH and extending in a penumbra-like pattern in surrounding (perilesional) normal appearing white matter (NAWM). However, DTI markers are not specific to tissue components, complicating interpretation of previous DTI findings. Myelin water imaging is a novel imaging technique that provides specific markers of myelin content (myelin water fraction: MWF) and interstitial fluid (geometric mean T2: GMT2). Here we combined DTI and myelin water imaging to examine tissue characteristics in WMHs and perilesional NAWM. Our goal was to establish a multimodal neuroimaging approach to track WMH progression.Methods 80 individuals (47 older adults and 33 individuals with chronic stroke) underwent neuroimaging and tissue segmentation. To measure perilesional NAWM, WMH masks were dilated in 2mm segments up to 10mm in distance from the WMH to measure perilesional NAWM. Fractional anisotropy (FA), mean diffusivity (MD), MWF, and GMT2 were extracted from WMHs and perilesional NAWM. We examined whether white matter metrics showed a spatial gradient of effects in perilesional NAWM, as a function of Distance from the WMH, and Group. We tested whether white matter metrics in the WMH lesion related to severity of cerebrovascular disease across the whole sample, indexed by whole brain WMH volume.Results We observed a spatial gradient of higher MD and GMT2, and lower FA, in perilesional NAWM and the WMH. In the chronic stroke group, MWF was reduced in the WMH lesion but did not show a spatial gradient in perilesional NAWM. Across the whole sample, white matter metrics within the WMH lesion related to whole-brain WMH volume; MD and GMT2 increased, and MWF decreased, with increasing WMH volume.Conclusions NAWM adjacent to WMHs exhibits characteristics of a transitional stage between healthy NAWM tissue and WMH lesions. This was observed in markers sensitive to interstitial fluid, but not in the specific marker of myelin concentration (MWF). Within the WMH, interstitial fluid was higher and myelin concentration was lower in individuals with more severe cerebrovascular disease. Our data suggests that fluid-sensitive imaging metrics (such as DTI) can identify NAWM at high risk of conversion to a WMH. In contrast, specific markers of myelin concentration (e.g., MWF) can be used to measure levels of demyelination in the WMH itself, which may be a useful marker for disease staging of advanced WMHs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by by an extramural grant from the Canadian Partnership for Stroke Recovery, and a project grant from the Canadian Institutes for Health Research (to L.A.B.: PJT-148535).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of British Columbia research ethics boards approved all aspects of study protocols.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data supporting the findings of this study are available on request from the corresponding author. The data are not publicly available because they contain information that could compromise the privacy of research participants.CSFcerebrospinal fluidDTIDiffusion tensor imagingFAfractional anisotropyGMT2geometric mean T2MDmean diffusivityMWFmyelin water fractionNAWMnormal appearing white matterROIregion of interestWMHwhite matter hyperintensity